Author:
Abd Almonaem Eman Rateb,Shaheen Ashraf Mohamed,Abdelrahman Amira M. N.,Hassan Waleed A.,Daay El Khair Noha Mohamed,Abdel Haie Omima Mohamed
Abstract
Abstract
Background
Interleukin-17F (IL-17F), one of the cytokines, is crucial in the pathophysiology of juvenile idiopathic arthritis (JIA). Therefore, we aimed to determine the relation between IL17F 7488A/G and IL17F 7383A/G single-nucleotide polymorphisms and JIA susceptibility and to explain their impact on the disease activity.
Methods
Genomic DNA of 70 patients with JIA and 70 age and sex-matched controls were extracted and typed for IL17F 7488A/G and IL17F 7383A/G single-nucleotide polymorphisms, using polymerase chain reaction with sequence-specific primers method, and compared between patients and controls.
Results
When compared to AA participants, children with the AG genotype of the IL17F 7488A/G and IL17F 7383A/G polymorphisms showed a substantially greater risk of JIA. Furthermore, children with the G allele were 2.8 folds more likely to have JIA than the A allele for IL17F 7488A/G polymorphism and 3.72 folds for IL17F 7383A/G polymorphism. Children with AG genotype of IL17F 7383A/G polymorphism were far more likely to have high activity JIA.
Conclusions
The G allele of both IL17F 7488A/G and IL17F7383 A/G polymorphisms is associated with increased JIA susceptibility, and JIA at High Disease Activity was more likely to develop in AG subjects of the IL17F 7383 A/G polymorphism.
Impact
The relationship between Interleukin-17F 7488A/G and 7383A/G polymorphisms and risk for JIA has not been recognized before.
Impact of Interleukin-17F 7488A/G and 7383A/G genotypes on JIA disease activity.
The G allele of both IL17F 7488A/G and IL17F7383 A/G polymorphisms are associated with increased JIA susceptibility.
AG genotype of Interleukin-17F 7383 A/G polymorphism compared to AA patients, had a higher probability of developing JIA at a High Disease Activity (HDA) level.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference39 articles.
1. Ringold, S. et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res. (Hoboken) 71, 717–734 (2019).
2. Petty, R. E. et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 31, 390–392 (2004).
3. Bovid, K. M. & Moore, M. D. Juvenile idiopathic arthritis for the pediatric orthopedic surgeon. Orthop. Clin. North Am. 50, 471–488 (2019).
4. Pickens, S. R. et al. IL-17 contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184, 3233–3241 (2010).
5. Möller, J. C. et al. IL10 promoter polymorphisms are associated with systemic-onset juvenile idiopathic arthritis (SoJIA). Clin. Exp. Rheumatol. 28, 912–918 (2010).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献